top of page
gradient banner_home page.png

Events

We'll be taking Dzuveo® on the road again in 2024, aiming to meet as many of you as possible. Come and say hello to the Aguettant team, we are going to be at the following events...

Dzuveo Logo Whiteout.png

Warwick

19th-20th September

The National Acute Pain Symposium 2024 (NAPS)

Cardiff

4th October

Welsh Pain Society Annual Conference

East Grinstead

7th November

South Thames Acute Pain Group Conference

Harrogate

25th-27th September

Association of Anaesthetists Annual Congress

Gateshead

8th-10th October

Royal College of Emergency Medicine Annual Scientific Conference (RCEM)

Exeter

21st-22nd November

Society of Anaesthetists of the South Western Region (SASWR) Annual Scientific Meeting

London

26th-27th September

British Association of Aesthetic Plastic Surgeons (BAAPS)

Copenhagen, Denmark

13th-16th October

European Emergency Medicine Congress (EUSEM 2024)

London

21st-22nd November

Royal College of Anaesthetists (RCoA) Winter Symposium

London

1st-2nd October

Future Surgery

Killarney, Ireland

17th-18th October

Irish Association of Emergency Medicine Annual Scientific Meeting

Analgesia, designed for your healthcare environment

Post operative
pain

Patients who mobilise sooner recover quicker (1). Dzuveo® supports you to gain control over patient comfort, so they can follow what's needed for their recovery.

Emergency &
trauma pain

In an emergency, relieving pain is an urgent priority. Dzuveo® takes effect quickly to make your patients comfortable, so you can work on their other clinical needs.

Procedural
pain

If a patient experiences pain during their procedure, whether it be a dressing change, burn debridement or an endoscopy, it could affect their overall outcome and clinical experience. Dzuveo®'s efficient analgesia supports you in getting patient pain under control.

Group 371a.png

Dzuveo® allows you to control your patient's pain urgently and non-invasively, prioritising patient care and comfort.

Find Out More...

Get in touch with us to find out more about how our Dzuveo® sublingual sufentanil 30 mcg tablet can support you in providing excellent patient care. 

 

An Aguettant team member will follow up with you shortly to provide additional information. 

Safety information

Dzuveo® is to be administered by a healthcare professional in a medically monitored setting only. A medically monitored setting must have equipment and personnel trained to detect and manage hypoventilation, and availability of supplemental oxygen and opioid antagonists, such as naloxone. Dzuveo® should only be prescribed and administered by healthcare professionals who are experienced in the management of opioid therapy; particularly opioid adverse reactions, such as respiratory depression

References 1. Twomey R, Matthews TW, Nakoneshny S, Schrag C, Chandarana SP, Matthews J, McKenzie D, Hart RD, Li N, Sauro KM, Dort JC. Impact of Early Mobilization on Recovery after Major Head and Neck Surgery with Free Flap Reconstruction. Cancers (Basel). 2021 Jun 8;13(12):2852. doi: 10.3390/cancers13122852. PMID: 34201003; PMCID: PMC8227616.

bottom of page